Literature DB >> 17414760

Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.

Isabelle Thomassin-Naggara1, Emile Daraï, Jinane Nassar-Slaba, Annie Cortez, Claude Marsault, Marc Bazot.   

Abstract

PURPOSE: The purpose of this study was to assess the accuracy of magnetic resonance imaging (MRI), particularly, dynamic MRI, in distinguishing ovarian fibromas from subserous uterine leiomyomas.
MATERIAL AND METHODS: Fifteen ovarian fibromas and 15 subserous uterine leiomyomas were retrospectively reviewed. All MR examinations included dynamic contrast-enhanced (DCE) sequences. Morphological criteria (size, T1 and T2 signals, ovarian tissue, associated uterine leiomyoma, and pelvic fluid), arterial vessels, time-intensity curves (maximal enhancement and signal intensity at 30, 60, and 90 seconds), and signal intensity on delayed T1-weighted images were compared between the 2 groups.
RESULTS: No significant difference in morphological criteria was noted between the 2 types of masses. Visualization of arterial vessels was more frequent in uterine leiomyomas than in ovarian fibromas (P= 0.002). The DCE MR enhancement rate was higher for uterine leiomyomas than for ovarian fibromas in terms of both maximal enhancement (P < 0.001) and enhancement rate at 30 (P = 0.009), 60 (P = 0.007), and 90 seconds (P = 0.0009). On delayed T1 postcontrast sequence, no statistical difference exists between signal intensity of ovarian fibromas and uterine leiomyomas.
CONCLUSION: Our findings suggest that DCE MRI can distinguish ovarian fibromas from uterine leiomyomas and should be used if sonography fails to show the origin of a pelvic mass.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414760     DOI: 10.1097/01.rct.0000237810.88251.9e

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  16 in total

1.  Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images.

Authors:  Wen-Peng Zhao; Jin-Yun Chen; Wen-Zhi Chen
Journal:  Exp Ther Med       Date:  2015-11-18       Impact factor: 2.447

2.  The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.

Authors:  Xian Li; Jun-Li Hu; Lai-Min Zhu; Xin-Hai Sun; Hua-Qiang Sheng; Ning Zhai; Xi-Bin Hu; Chu-Ran Sun; Bin Zhao
Journal:  Tumour Biol       Date:  2015-02-28

3.  Pelvic tumors with normal-appearing shapes of ovaries and uterus presenting as an emergency (Review).

Authors:  Atsushi Imai; Satoshi Ichigo; Hiroshi Takagi; Kazutoshi Matsunami; Sadayoshi Watanabe; Takayuki Murase; Tsuneko Ikeda
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

4.  Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation.

Authors:  Livia Bernardin; Philip Dilks; Sidath Liyanage; Marc E Miquel; Anju Sahdev; Andrea Rockall
Journal:  Eur Radiol       Date:  2011-11-18       Impact factor: 5.315

5.  Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass?

Authors:  Philip Dilks; Priya Narayanan; Rodney Reznek; Anju Sahdev; Andrea Rockall
Journal:  Eur Radiol       Date:  2010-04-25       Impact factor: 5.315

Review 6.  Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.

Authors:  Muhammad O Awiwi; Mohamed Badawy; Akram M Shaaban; Christine O Menias; Jeanne M Horowitz; Moataz Soliman; Corey T Jensen; Ayman H Gaballah; Juan J Ibarra-Rovira; Myra K Feldman; Mindy X Wang; Peter S Liu; Khaled M Elsayes
Journal:  Abdom Radiol (NY)       Date:  2022-05-13

Review 7.  Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists.

Authors:  Mariana Horta; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

8.  Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study.

Authors:  Song Peng; Lian Zhang; Liang Hu; Jinyun Chen; Jin Ju; Xi Wang; Rong Zhang; Zhibiao Wang; Wenzhi Chen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

9.  A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.

Authors:  Mei-Jie Yang; Ren-Qiang Yu; Wen-Zhi Chen; Jin-Yun Chen; Zhi-Biao Wang
Journal:  Front Surg       Date:  2021-06-04

Review 10.  Added Value of Assessing Adnexal Masses with Advanced MRI Techniques.

Authors:  I Thomassin-Naggara; D Balvay; A Rockall; M F Carette; M Ballester; E Darai; M Bazot
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.